VRB-101
A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Verdiva Bio Dev Limited · Phase 2 · Terminated · Enrollment 8
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| VRB-101 (Active Arm 1) | n/r | n/r | n/r | n/r | n/r |
| VRB-101 (Active Arm 2) | n/r | n/r | n/r | n/r | n/r |
| VRB-101 (Active Arm 3) | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.